Lemonade Soared by 94% in 2025, but Here's Another Financial Stock to Buy in 2026

Affirm reported a strong fiscal 2026 Q1 (ended Sept. 30, 2025) with revenue up 34% year-over-year, GMV up 42% and net income of $81 million versus a $100 million loss a year earlier; management expects Q2 revenue to rise 10–14% sequentially and GMV to increase 20–23% with a higher operating margin at the midpoint. Strategic catalysts include an application for an industrial loan bank charter (which would allow deposit-taking and reduce loan partnership costs) and potential regulatory shifts—specifically a proposed cap on credit-card interest rates—that could redirect consumers to BNPL products. By contrast Lemonade’s 94% 2025 rally is seen as less likely to repeat given unprofitability and a high valuation. Analysts are broadly positive on Affirm (70% buy, median price target $95, ~40% upside from the then-current price).

Analysis

Market structure: Affirm (AFRM) is positioned as a direct beneficiary of a rotation toward profitable fintech — its recent +34% revenue and +42% GMV give it a growth+profitability narrative that attracts risk-on flows. Winners: BNPL providers, merchants who gain conversion lift, fintech platforms that cut bank-intermediation fees; losers: card issuers and incumbent partner banks that currently capture loan-originations margins. Cross-asset: a sizable reweight into AFRM would be risk-on — push yields modestly higher, compress credit spreads, lower equity volatility in payments; FX flows favor USD on tech buying, commodities largely neutral.

Risk assessment: Key tail risks are (1) regulatory intervention (credit-card rate cap or BNPL consumer rules) — low-to-medium probability but could cut AFRM volume 15–30% if passed; (2) ILC denial or materially delayed approval (30–60 days–9 months) which keeps origination costs high; (3) credit-cycle shock where charge-offs rise >200bps and profitability reverses. Immediate (days): earnings prints and guidance; short-term (1–3 months): policy headlines and ILC milestones; long-term (6–24 months): integration of banking operations and sustainable NIMs.

Trade implications: Direct long AFRM exposure is preferred vs insurtech LMND (valuation and unprofitability risk). Implement a staged 2–3% core long in AFRM (25% now, add on 15% pullbacks) and hedge with a 3–6 month 20–30% OTM call spread (limit cost to ~0.5–1% portfolio). Small tactical short or put-spread (0.5–1%) on LMND given stretched multiple and weak path to profit. Pair: long AFRM / short COF (or MA if consumer spending weak) to express BNPL share gains vs card incumbents. Time entries within next 2–6 weeks and re-evaluate at the ILC decision or next two quarters of GMV prints.

Contrarian angles: Consensus underestimates the compliance cost of a bank charter — if AFRM gains an ILC it could face 150–400bps higher funding and capital costs initially, compressing NIMs and slowing EPS accretion, a risk markets may not price. Conversely, LMND’s AI-driven claims automation could sustain operating leverage if loss ratios remain stable, so a small long-convexity position in LMND recovery warrants consideration only after conviction on loss-ratio improvement. Historical parallel: LendingClub/SoFi transitions show charter wins are priced as optionality then re-priced when regulatory cost realities hit; plan for a re-rating window of 3–12 months post-decision.

Key Decisions for Investors

• Establish a 2–3% core long position in AFRM (NASDAQ: AFRM); tranche 25% immediately, add 50% on a 15% pullback, hold remainder to an ILC-approval or next two quarterly GMV prints; stop-loss: cut if two consecutive quarters show GMV growth <20% or net income turns negative.
• Buy a 3–6 month AFRM call spread ~20–25% OTM sized at 0.5–1% of portfolio to play upside into potential ILC/legislative catalysts while capping premium; close if spread reaches 60% of max profit or 2 weeks before earnings.
• Initiate a tactical 0.5–1% short or put-spread position in LMND (NYSE: LMND) targeting a 30–50% downside over 6–12 months given valuation and unprofitability; exit if loss-ratio improvement sustains two consecutive quarters of margin expansion.
• Implement a pair trade: long AFRM (1–2%) / short COF (Capital One, 1–2%) to express BNPL share gains vs card issuers; monitor for regulatory developments — trim positions if policy probability of a credit-card rate cap exceeds 30% within 90 days.
• Monitor three binary catalysts over the next 90–270 days and act: (1) AFRM ILC application decision (timeline 3–9 months), (2) any federal BNPL/credit-card interest cap legislation (watch Congressional filings/news), (3) next two AFRM quarterly GMV and net income prints — reduce exposure if any two catalysts turn negative.